DNA & Genetics Sarepta CEO Defends Elevidys as Q4 Sales Fall ShortBy adminJanuary 18, 20260 SAN FRANCISCO—No sooner did the J.P. Morgan 44th Annual Healthcare Conference kick off when Sarepta Therapeutics (SRPT) saw its stock…
